Drugs interactions for Kerendia®
- 63 Major drug interactions (including ingredients like Abametapir, Amiodarone, Apalutamide)
- 351 Moderate drug interactions (including ingredients like Abatacept, Abiraterone, Acalabrutinib)
- 403 Minor drug interactions (including ingredients like Abacavir, Acebutolol, Aceclofenac)
817 interactions for Kerendia®The serum concentration of Finerenone can be increased when it is combined with Abametapir.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Amiodarone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Apalutamide.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Atazanavir.The therapeutic efficacy of Finerenone can be decreased when used in combination with Bexarotene.The therapeutic efficacy of Finerenone can be decreased when used in combination with Bosentan.The metabolism of Brigatinib can be decreased when combined with Finerenone.The metabolism of Finerenone can be decreased when combined with Candesartan cilexetil.The therapeutic efficacy of Finerenone can be decreased when used in combination with Carbamazepine.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Clarithromycin.The metabolism of Finerenone can be decreased when combined with Clopidogrel.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Conivaptan.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Curcumin.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Danazol.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Darunavir.The therapeutic efficacy of Finerenone can be decreased when used in combination with Dexamethasone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Dexamethasone acetate.The therapeutic efficacy of Finerenone can be decreased when used in combination with Echinacea.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Econazole.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Efavirenz.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Elvitegravir.The therapeutic efficacy of Finerenone can be decreased when used in combination with Enzalutamide.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Ergotamine.The therapeutic efficacy of Finerenone can be decreased when used in combination with Etravirine.The metabolism of Finerenone can be decreased when combined with Felodipine.The metabolism of Fluorouracil can be decreased when combined with Finerenone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Fosphenytoin.The metabolism of Finerenone can be decreased when combined with Gemfibrozil.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Indinavir.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Itraconazole.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Ketoconazole.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Levoketoconazole.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Lonafarnib.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Lopinavir.The therapeutic efficacy of Finerenone can be decreased when used in combination with Lumacaftor.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Methimazole.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Midostaurin.The therapeutic efficacy of Finerenone can be decreased when used in combination with Mitotane.The therapeutic efficacy of Finerenone can be decreased when used in combination with Modafinil.The metabolism of Finerenone can be decreased when combined with Mometasone furoate.The therapeutic efficacy of Finerenone can be decreased when used in combination with Nafcillin.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Nefazodone.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Nelfinavir.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Nilotinib.The metabolism of Paclitaxel can be decreased when combined with Finerenone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Pentobarbital.The therapeutic efficacy of Finerenone can be decreased when used in combination with Phenobarbital.The therapeutic efficacy of Finerenone can be decreased when used in combination with Phenytoin.The metabolism of Ponatinib can be decreased when combined with Finerenone.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Posaconazole.The therapeutic efficacy of Finerenone can be decreased when used in combination with Primidone.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Ribociclib.The therapeutic efficacy of Finerenone can be decreased when used in combination with Rifampicin.The therapeutic efficacy of Finerenone can be decreased when used in combination with Rifapentine.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Ritonavir.The metabolism of Finerenone can be decreased when combined with Salmeterol.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Saquinavir.The metabolism of Finerenone can be increased when combined with Secobarbital.The risk or severity of hyperkalemia can be increased when Finerenone is combined with Spironolactone.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Stiripentol.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Telithromycin.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Tipranavir.The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Voriconazole.The metabolism of Finerenone can be increased when combined with Abatacept.The metabolism of Finerenone can be decreased when combined with Abiraterone.The serum concentration of Finerenone can be increased when it is combined with Acalabrutinib.The serum concentration of Finerenone can be increased when it is combined with Acetaminophen.The serum concentration of Finerenone can be increased when it is combined with Acetazolamide.Acetylsalicylic acid may decrease the excretion rate of Finerenone which could result in a higher serum level.The serum concentration of Finerenone can be increased when it is combined with Adagrasib.The metabolism of Finerenone can be increased when combined with Adalimumab.The serum concentration of Finerenone can be increased when it is combined with Aldesleukin.The therapeutic efficacy of Finerenone can be decreased when used in combination with Alfentanil.The metabolism of Finerenone can be decreased when combined with Almotriptan.The serum concentration of Finerenone can be increased when it is combined with Alpelisib.The metabolism of Finerenone can be decreased when combined with Amitriptyline.The metabolism of Finerenone can be increased when combined with Anakinra.The metabolism of Finerenone can be decreased when combined with Anastrozole.The metabolism of Finerenone can be decreased when combined with Antipyrine.The metabolism of Finerenone can be decreased when combined with Apixaban.The metabolism of Finerenone can be decreased when combined with Apomorphine.The metabolism of Finerenone can be increased when combined with Apremilast.The serum concentration of Finerenone can be increased when it is combined with Aprepitant.The metabolism of Finerenone can be decreased when combined with Atorvastatin.The serum concentration of Avanafil can be increased when it is combined with Finerenone.The metabolism of Finerenone can be decreased when combined with Azelastine.The therapeutic efficacy of Finerenone can be decreased when used in combination with Benzhydrocodone.The metabolism of Finerenone can be decreased when combined with Benzyl alcohol.The metabolism of Finerenone can be decreased when combined with Berotralstat.The metabolism of Finerenone can be increased when combined with Betamethasone.The serum concentration of Finerenone can be increased when it is combined with Bicalutamide.The metabolism of Finerenone can be increased when combined with Bimekizumab.The risk or severity of dehydration can be increased when Finerenone is combined with Bisacodyl.The serum concentration of Finerenone can be increased when it is combined with Bosutinib.The serum concentration of Finerenone can be increased when it is combined with Brentuximab vedotin.The serum concentration of Finerenone can be increased when it is combined with Bromocriptine.The serum concentration of Finerenone can be increased when it is combined with Buprenorphine.The therapeutic efficacy of Finerenone can be decreased when used in combination with Butorphanol.The metabolism of Finerenone can be decreased when combined with Cabazitaxel.The serum concentration of Finerenone can be increased when it is combined with Cabergoline.The risk or severity of dehydration can be increased when Finerenone is combined with Calcium polycarbophil.The metabolism of Finerenone can be increased when combined with Canakinumab.The metabolism of Finerenone can be decreased when combined with Cannabidiol.The serum concentration of Finerenone can be increased when it is combined with Capsaicin.The risk or severity of dehydration can be increased when Finerenone is combined with Carboxymethylcellulose.The risk or severity of dehydration can be increased when Finerenone is combined with Castor oil.The metabolism of Finerenone can be decreased when combined with Celecoxib.The serum concentration of Finerenone can be decreased when it is combined with Cenobamate.The serum concentration of Finerenone can be increased when it is combined with Ceritinib.The metabolism of Finerenone can be increased when combined with Certolizumab pegol.The serum concentration of Finerenone can be increased when it is combined with Chloramphenicol.The metabolism of Finerenone can be decreased when combined with Chloroquine.The serum concentration of Finerenone can be increased when it is combined with Cimetidine.The serum concentration of Finerenone can be increased when it is combined with Ciprofloxacin.The serum concentration of Finerenone can be increased when it is combined with Citalopram.The serum concentration of Finerenone can be increased when it is combined with Clevidipine.The serum concentration of Finerenone can be increased when it is combined with Clozapine.The serum concentration of Finerenone can be increased when it is combined with Cobicistat.The therapeutic efficacy of Finerenone can be decreased when used in combination with Codeine.The serum concentration of Finerenone can be increased when it is combined with Crizotinib.The metabolism of Finerenone can be increased when combined with Cyclophosphamide.The serum concentration of Finerenone can be increased when it is combined with Cyclosporine.The serum concentration of Finerenone can be increased when it is combined with Dabrafenib.The serum concentration of Finerenone can be increased when it is combined with Dalfopristin.The metabolism of Finerenone can be decreased when combined with Daprodustat.The metabolism of Finerenone can be decreased when combined with Dapsone.The metabolism of Finerenone can be decreased when combined with Dasabuvir.The serum concentration of Finerenone can be increased when it is combined with Dasatinib.The serum concentration of Finerenone can be increased when it is combined with Daunorubicin.The metabolism of Finerenone can be decreased when combined with Deferasirox.The serum concentration of Finerenone can be increased when it is combined with Desipramine.The serum concentration of Finerenone can be increased when it is combined with Desvenlafaxine.The serum concentration of Finerenone can be increased when it is combined with Dextropropoxyphene.The serum concentration of Finerenone can be increased when it is combined with Diazepam.The metabolism of Finerenone can be decreased when combined with Diclofenac.The therapeutic efficacy of Finerenone can be decreased when used in combination with Dihydrocodeine.The serum concentration of Finerenone can be increased when it is combined with Dihydroergotamine.The serum concentration of Finerenone can be increased when it is combined with Diltiazem.The serum concentration of Finerenone can be increased when it is combined with Dimethyl sulfoxide.The therapeutic efficacy of Finerenone can be decreased when used in combination with Diphenoxylate.The risk or severity of dehydration can be increased when Finerenone is combined with Dipotassium phosphate.The serum concentration of Finerenone can be increased when it is combined with Docetaxel.The risk or severity of dehydration can be increased when Finerenone is combined with Docusate.The serum concentration of Finerenone can be increased when it is combined with Doxorubicin.The serum concentration of Finerenone can be increased when it is combined with Dronabinol.The serum concentration of Finerenone can be increased when it is combined with Dronedarone.The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Finerenone.The metabolism of Finerenone can be decreased when combined with Elagolix.The serum concentration of Finerenone can be increased when it is combined with Elbasvir.The metabolism of Finerenone can be decreased when combined with Eltrombopag.The therapeutic efficacy of Finerenone can be decreased when used in combination with Eluxadoline.The metabolism of Finerenone can be increased when combined with Emapalumab.The serum concentration of Finerenone can be increased when it is combined with Enasidenib.The serum concentration of Finerenone can be increased when it is combined with Encorafenib.The serum concentration of Finerenone can be increased when it is combined with Epcoritamab.The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Finerenone.The serum concentration of Finerenone can be increased when it is combined with Epinephrine.The serum concentration of Finerenone can be increased when it is combined with Erlotinib.The serum concentration of Finerenone can be increased when it is combined with Erythromycin.The risk or severity of hyperkalemia can be increased when Finerenone is combined with Estetrol.The metabolism of Finerenone can be decreased when combined with Estradiol.The metabolism of Finerenone can be decreased when combined with Estradiol acetate.The metabolism of Finerenone can be decreased when combined with Estradiol cypionate.The metabolism of Finerenone can be decreased when combined with Estradiol valerate.The metabolism of Finerenone can be decreased when combined with Eszopiclone.The metabolism of Finerenone can be increased when combined with Etanercept.The serum concentration of Finerenone can be increased when it is combined with Ethanol.The metabolism of Finerenone can be decreased when combined with Ethinylestradiol.The serum concentration of Finerenone can be increased when it is combined with Etoposide.The metabolism of Finerenone can be decreased when combined with Etrasimod.The serum concentration of Finerenone can be increased when it is combined with Everolimus.The serum concentration of Finerenone can be increased when it is combined with Fedratinib.The therapeutic efficacy of Finerenone can be decreased when used in combination with Fentanyl.The serum concentration of Finerenone can be increased when it is combined with Fexinidazole.The serum concentration of Finerenone can be increased when it is combined with Fluconazole.The serum concentration of Finerenone can be increased when it is combined with Fluticasone propionate.The serum concentration of Finerenone can be increased when it is combined with Fluvastatin.The serum concentration of Finerenone can be increased when it is combined with Fluvoxamine.The serum concentration of Finerenone can be increased when it is combined with Fosaprepitant.The serum concentration of Finerenone can be increased when it is combined with Fosnetupitant.The serum concentration of Finerenone can be increased when it is combined with Fostamatinib.The risk or severity of dehydration can be increased when Finerenone is combined with Frangula purshiana bark.The metabolism of Finerenone can be decreased when combined with Fruquintinib.The serum concentration of Finerenone can be increased when it is combined with Fusidic acid.The metabolism of Finerenone can be decreased when combined with Genistein.The metabolism of Finerenone can be decreased when combined with Glasdegib.The serum concentration of Finerenone can be increased when it is combined with Glofitamab.The risk or severity of dehydration can be increased when Finerenone is combined with Gluconic Acid.The serum concentration of Finerenone can be increased when it is combined with Glyburide.The risk or severity of dehydration can be increased when Finerenone is combined with Glycerin.The metabolism of Finerenone can be increased when combined with Golimumab.The serum concentration of Haloperidol can be increased when it is combined with Finerenone.The serum concentration of Finerenone can be increased when it is combined with Hydralazine.The therapeutic efficacy of Finerenone can be decreased when used in combination with Hydrocodone.The metabolism of Finerenone can be increased when combined with Hydrocortisone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Hydromorphone.The metabolism of Finerenone can be decreased when combined with Hydroxychloroquine.The metabolism of Finerenone can be decreased when combined with Ibuprofen.The serum concentration of Finerenone can be increased when it is combined with Idelalisib.The serum concentration of Finerenone can be increased when it is combined with Ifosfamide.The serum concentration of Finerenone can be increased when it is combined with Imatinib.The metabolism of Finerenone can be increased when combined with Infliximab.The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Finerenone.The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Finerenone.The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Finerenone.The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Finerenone.The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Finerenone.The therapeutic efficacy of Insulin human can be decreased when used in combination with Finerenone.The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Finerenone.The metabolism of Iptacopan can be decreased when combined with Finerenone.The serum concentration of Finerenone can be increased when it is combined with Irbesartan.The serum concentration of Finerenone can be increased when it is combined with Isavuconazonium.The serum concentration of Finerenone can be increased when it is combined with Isoniazid.The serum concentration of Finerenone can be increased when it is combined with Isradipine.The metabolism of Finerenone can be decreased when combined with Istradefylline.The serum concentration of Finerenone can be increased when it is combined with Ivacaftor.The metabolism of Finerenone can be increased when combined with Ivosidenib.The metabolism of Finerenone can be decreased when combined with Ketamine.The metabolism of Finerenone can be decreased when combined with Ketorolac.The risk or severity of dehydration can be increased when Finerenone is combined with Lactitol.The risk or severity of dehydration can be increased when Finerenone is combined with Lactulose.The serum concentration of Finerenone can be increased when it is combined with Lanreotide.The serum concentration of Finerenone can be increased when it is combined with Lansoprazole.The serum concentration of Finerenone can be increased when it is combined with Lapatinib.The serum concentration of Finerenone can be increased when it is combined with Letermovir.The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Finerenone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Levorphanol.The metabolism of Finerenone can be decreased when combined with Levothyroxine.The risk or severity of dehydration can be increased when Finerenone is combined with Linaclotide.The serum concentration of Finerenone can be increased when it is combined with Linagliptin.The serum concentration of Finerenone can be increased when it is combined with Linzagolix.The serum concentration of Finerenone can be increased when it is combined with Lomitapide.The metabolism of Finerenone can be decreased when combined with Loperamide.The metabolism of Finerenone can be decreased when combined with Loratadine.The risk or severity of dehydration can be increased when Finerenone is combined with Lubiprostone.The serum concentration of Finerenone can be increased when it is combined with Luliconazole.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium acetate.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium carbonate.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium citrate.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium glycinate.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium hydroxide.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium oxide.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium sulfate.The risk or severity of dehydration can be increased when Finerenone is combined with Magnesium trisilicate.The risk or severity of dehydration can be increased when Finerenone is combined with Mannitol.The serum concentration of Finerenone can be decreased when it is combined with Mavacamten.The serum concentration of Finerenone can be increased when it is combined with Mavorixafor.The metabolism of Finerenone can be decreased when combined with Medroxyprogesterone acetate.The serum concentration of Finerenone can be increased when it is combined with Mefloquine.The therapeutic efficacy of Finerenone can be decreased when used in combination with Meloxicam.The therapeutic efficacy of Finerenone can be decreased when used in combination with Meperidine.The serum concentration of Finerenone can be increased when it is combined with Methadone.The risk or severity of dehydration can be increased when Finerenone is combined with Methylcellulose.The serum concentration of Finerenone can be increased when it is combined with Methylene blue.The serum concentration of Finerenone can be increased when it is combined with Methylergometrine.The serum concentration of Finerenone can be increased when it is combined with Metronidazole.The serum concentration of Finerenone can be increased when it is combined with Metyrapone.The serum concentration of Finerenone can be increased when it is combined with Miconazole.The serum concentration of Finerenone can be increased when it is combined with Midazolam.The serum concentration of Finerenone can be increased when it is combined with Mifepristone.The serum concentration of Finerenone can be increased when it is combined with Milnacipran.The risk or severity of dehydration can be increased when Finerenone is combined with Mineral oil.The serum concentration of Finerenone can be increased when it is combined with Mirtazapine.The metabolism of Finerenone can be increased when combined with Mitapivat.The risk or severity of dehydration can be increased when Finerenone is combined with Monopotassium phosphate.The metabolism of Finerenone can be decreased when combined with Montelukast.The metabolism of Finerenone can be decreased when combined with Morphine.The metabolism of Finerenone can be decreased when combined with Mycophenolate mofetil.The therapeutic efficacy of Finerenone can be decreased when used in combination with Nalbuphine.The therapeutic efficacy of Finerenone can be decreased when used in combination with Naloxegol.The therapeutic efficacy of Finerenone can be decreased when used in combination with Naltrexone.The metabolism of Finerenone can be decreased when combined with Naproxen.The serum concentration of Finerenone can be increased when it is combined with Netupitant.The serum concentration of Finerenone can be increased when it is combined with Nicardipine.The metabolism of Finerenone can be decreased when combined with Nilutamide.The metabolism of Finerenone can be increased when combined with Nirogacestat.The serum concentration of Finerenone can be increased when it is combined with Nitric Oxide.The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Finerenone.The serum concentration of Finerenone can be increased when it is combined with Octreotide.The serum concentration of Finerenone can be increased when it is combined with Olaparib.The therapeutic efficacy of Finerenone can be decreased when used in combination with Oliceridine.The metabolism of Finerenone can be decreased when combined with Olodaterol.The metabolism of Finerenone can be decreased when combined with Ombitasvir.The therapeutic efficacy of Finerenone can be decreased when used in combination with Opium.The serum concentration of Finerenone can be increased when it is combined with Orphenadrine.The serum concentration of Finerenone can be increased when it is combined with Osilodrostat.The serum concentration of Finerenone can be increased when it is combined with Oxybutynin.The therapeutic efficacy of Finerenone can be decreased when used in combination with Oxycodone.The serum concentration of Finerenone can be increased when it is combined with Oxymetholone.The therapeutic efficacy of Finerenone can be decreased when used in combination with Oxymorphone.The metabolism of Finerenone can be decreased when combined with Ozanimod.The serum concentration of Finerenone can be increased when it is combined with Palbociclib.The serum concentration of Finerenone can be increased when it is combined with Paroxetine.The serum concentration of Finerenone can be increased when it is combined with Pasireotide.The serum concentration of Finerenone can be increased when it is combined with Pazopanib.The therapeutic efficacy of Finerenone can be decreased when used in combination with Pentazocine.The serum concentration of Finerenone can be increased when it is combined with Peppermint oil.The serum concentration of Finerenone can be increased when it is combined with Phenelzine.The risk or severity of dehydration can be increased when Finerenone is combined with Picosulfuric acid.The serum concentration of Finerenone can be increased when it is combined with Pimozide.The metabolism of Finerenone can be decreased when combined with Pioglitazone.The serum concentration of Finerenone can be increased when it is combined with Piperine.The metabolism of Finerenone can be decreased when combined with Piroxicam.The metabolism of Finerenone can be decreased when combined with Pirtobrutinib.The serum concentration of Finerenone can be decreased when it is combined with Pitolisant.The risk or severity of dehydration can be increased when Finerenone is combined with Plantago seed.The risk or severity of dehydration can be increased when Finerenone is combined with Plecanatide.The risk or severity of dehydration can be increased when Finerenone is combined with Polyethylene glycol.Potassium may increase the hyperkalemic activities of Finerenone.Potassium acetate may increase the hyperkalemic activities of Finerenone.Potassium bicarbonate may increase the hyperkalemic activities of Finerenone.The risk or severity of dehydration can be increased when Finerenone is combined with Potassium bitartrate.Potassium carbonate may increase the hyperkalemic activities of Finerenone.Potassium cation may increase the hyperkalemic activities of Finerenone.Potassium chloride may increase the hyperkalemic activities of Finerenone.Potassium citrate may increase the hyperkalemic activities of Finerenone.Potassium hydroxide may increase the hyperkalemic activities of Finerenone.Potassium Iodide may increase the hyperkalemic activities of Finerenone.Potassium nitrate may increase the hyperkalemic activities of Finerenone.The risk or severity of dehydration can be increased when Finerenone is combined with Potassium sulfate.Potassium triiodide may increase the hyperkalemic activities of Finerenone.The serum concentration of Finerenone can be increased when it is combined with Pralsetinib.The metabolism of Finerenone can be increased when combined with Prednisolone phosphate.The serum concentration of Finerenone can be increased when it is combined with Primaquine.The metabolism of Finerenone can be increased when combined with Probenecid.The serum concentration of Finerenone can be increased when it is combined with Propofol.The risk or severity of dehydration can be increased when Finerenone is combined with Prucalopride.The serum concentration of Finerenone can be increased when it is combined with Quinidine.The serum concentration of Finerenone can be increased when it is combined with Quinine.The serum concentration of Finerenone can be increased when it is combined with Quinupristin.The serum concentration of Finerenone can be increased when it is combined with Rabeprazole.The risk or severity of Cardiac Arrhythmia can be increased when Racepinephrine is combined with Finerenone.The serum concentration of Finerenone can be increased when it is combined with Raloxifene.The serum concentration of Finerenone can be increased when it is combined with Ranolazine.The serum concentration of Finerenone can be increased when it is combined with Regorafenib.The serum concentration of Finerenone can be increased when it is combined with Remdesivir.The therapeutic efficacy of Finerenone can be decreased when used in combination with Remifentanil.The metabolism of Finerenone can be decreased when combined with Repaglinide.The serum concentration of Finerenone can be increased when it is combined with Repotrectinib.The metabolism of Finerenone can be increased when combined with Rilonacept.The serum concentration of Finerenone can be increased when it is combined with Rilpivirine.The metabolism of Finerenone can be decreased when combined with Riociguat.The serum concentration of Finerenone can be increased when it is combined with Ritlecitinib.The metabolism of Finerenone can be decreased when combined with Rosiglitazone.The serum concentration of Finerenone can be increased when it is combined with Rucaparib.The serum concentration of Finerenone can be increased when it is combined with Rutin.The serum concentration of Finerenone can be increased when it is combined with Sarilumab.The serum concentration of Finerenone can be decreased when it is combined with Satralizumab.The metabolism of Finerenone can be increased when combined with Secukinumab.The metabolism of Finerenone can be decreased when combined with Selegiline.The metabolism of Finerenone can be decreased when combined with Selexipag.The serum concentration of Finerenone can be increased when it is combined with Selpercatinib.The metabolism of Finerenone can be decreased when combined with Selumetinib.The risk or severity of dehydration can be increased when Finerenone is combined with Senna leaf.The risk or severity of dehydration can be increased when Finerenone is combined with Sennosides.The serum concentration of Finerenone can be increased when it is combined with Siltuximab.The metabolism of Finerenone can be decreased when combined with Simvastatin.The metabolism of Finerenone can be decreased when combined with Sitagliptin.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium ascorbate.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium cation.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium fluorophosphate.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium phosphate, dibasic.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium phosphate, dibasic, unspecified form.Finerenone may increase the nephrotoxic activities of Sodium phosphate, monobasic.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium phosphate, monobasic, unspecified form.The risk or severity of dehydration can be increased when Finerenone is combined with Sodium sulfate.The serum concentration of Finerenone can be increased when it is combined with Sorafenib.The risk or severity of dehydration can be increased when Finerenone is combined with Sorbitol.The serum concentration of Finerenone can be decreased when it is combined with Sotorasib.The therapeutic efficacy of Finerenone can be decreased when used in combination with Sufentanil.The metabolism of Finerenone can be decreased when combined with Sulfadiazine.The serum concentration of Finerenone can be increased when it is combined with Sulfamethoxazole.The risk or severity of dehydration can be increased when Finerenone is combined with Sulfate ion.The serum concentration of Finerenone can be increased when it is combined with Sunitinib.The serum concentration of Finerenone can be increased when it is combined with Tacrolimus.The serum concentration of Finerenone can be increased when it is combined with Tamoxifen.The metabolism of Finerenone can be decreased when combined with Tazarotene.The risk or severity of dehydration can be increased when Finerenone is combined with Tegaserod.The serum concentration of Finerenone can be decreased when it is combined with Telotristat ethyl.The serum concentration of Finerenone can be increased when it is combined with Teniposide.The metabolism of Finerenone can be decreased when combined with Terbinafine.The metabolism of Finerenone can be decreased when combined with Teriflunomide.The serum concentration of Finerenone can be increased when it is combined with Testosterone cypionate.The serum concentration of Finerenone can be increased when it is combined with Testosterone enanthate.The serum concentration of Finerenone can be increased when it is combined with Testosterone undecanoate.The serum concentration of Finerenone can be increased when it is combined with Tetracycline.The metabolism of Finerenone can be decreased when combined with Theophylline.The serum concentration of Finerenone can be increased when it is combined with Ticagrelor.The serum concentration of Finerenone can be increased when it is combined with Tioconazole.The metabolism of Finerenone can be increased when combined with Tocilizumab.The serum concentration of Finerenone can be increased when it is combined with Topotecan.The metabolism of Finerenone can be decreased when combined with Torasemide.The metabolism of Finerenone can be decreased when combined with Tovorafenib.The therapeutic efficacy of Finerenone can be decreased when used in combination with Tramadol.The serum concentration of Finerenone can be increased when it is combined with Tranylcypromine.The serum concentration of Finerenone can be increased when it is combined with Treosulfan.The metabolism of Finerenone can be decreased when combined with Treprostinil.The serum concentration of Finerenone can be increased when it is combined with Triclabendazole.The metabolism of Finerenone can be decreased when combined with Trimethoprim.The serum concentration of Finerenone can be increased when it is combined with Trofinetide.The metabolism of Tucatinib can be decreased when combined with Finerenone.The serum concentration of Finerenone can be increased when it is combined with Valproic acid.The metabolism of Finerenone can be decreased when combined with Velpatasvir.The metabolism of Finerenone can be decreased when combined with Vemurafenib.The serum concentration of Finerenone can be increased when it is combined with Venetoclax.The serum concentration of Finerenone can be increased when it is combined with Verapamil.The serum concentration of Finerenone can be increased when it is combined with Viloxazine.The serum concentration of Finerenone can be increased when it is combined with Vinblastine.The metabolism of Finerenone can be decreased when combined with Vortioxetine.The metabolism of Finerenone can be decreased when combined with Voxilaprevir.The serum concentration of Finerenone can be increased when it is combined with Zafirlukast.The metabolism of Finerenone can be decreased when combined with Zidovudine.The serum concentration of Finerenone can be increased when it is combined with Ziprasidone.Finerenone may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Acebutolol is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Aceclofenac is combined with Finerenone.Finerenone may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Albuterol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Finerenone.Finerenone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Amiloride is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Ammonium chloride is combined with Finerenone.Finerenone may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Antithrombin III human which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Arformoterol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Atenolol is combined with Finerenone.Finerenone may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Azelaic acid which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Finerenone.Finerenone may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Balsalazide is combined with Finerenone.Finerenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Benazepril is combined with Finerenone.Finerenone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Finerenone.Finerenone may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Finerenone.Finerenone may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.The metabolism of Finerenone can be decreased when combined with Cabozantinib.The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Finerenone.Finerenone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Captopril is combined with Finerenone.Finerenone may increase the excretion rate of Carbidopa which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Finerenone.Finerenone may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Choline salicylate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Chromic chloride which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Chromium which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Clorazepic acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Clove oil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Cyanocobalamin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Finerenone.Finerenone may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dexmedetomidine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dienogest which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Digoxin is combined with Finerenone.Finerenone may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Disopyramide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of DL-Methylephedrine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dobutamine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Doxepin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Drospirenone is combined with Finerenone.Finerenone may increase the excretion rate of Duloxetine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.Empagliflozin may increase the diuretic activities of Finerenone.The risk or severity of hyperkalemia can be increased when Enalapril is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Enalaprilat is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Finerenone.Finerenone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Finerenone.Finerenone may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Esmolol is combined with Finerenone.Finerenone may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Ethenzamide is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Etodolac is combined with Finerenone.Finerenone may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Eucalyptus oil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Evening primrose oil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fenoldopam which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Finerenone.Finerenone may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Fish oil is combined with Finerenone.Finerenone may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Florbetaben F-18 which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Florbetapir (18F) which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Flucytosine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fludeoxyglucose (18F) which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fluocinolone acetonide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Flurbiprofen is combined with Finerenone.Finerenone may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Finerenone.Finerenone may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Heparin is combined with Finerenone.Finerenone may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Icosapent is combined with Finerenone.Finerenone may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Finerenone.Finerenone may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Iobenguane sulfate I-123 which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Iothalamic acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Isosulfan blue which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Labetalol is combined with Finerenone.Finerenone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Lamotrigine is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Landiolol is combined with Finerenone.Finerenone may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Levocarnitine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Levomenthol is combined with Finerenone.Finerenone may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Levosalbutamol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Finerenone.Finerenone may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Lixisenatide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Losartan is combined with Finerenone.Finerenone may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Magnesium salicylate is combined with Finerenone.Finerenone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Mefenamic acid is combined with Finerenone.Finerenone may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Finerenone.Finerenone may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Metaxalone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Metformin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Methoxsalen which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Methsuximide is combined with Finerenone.Finerenone may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Finerenone.The metabolism of Finerenone can be increased when combined with Metreleptin.Finerenone may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Moexipril is combined with Finerenone.Finerenone may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of N-acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Nadolol is combined with Finerenone.Finerenone may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Nebivolol is combined with Finerenone.Finerenone may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Finerenone.Finerenone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Finerenone.The serum concentration of Finerenone can be decreased when it is combined with Omaveloxolone.Finerenone may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Finerenone.Finerenone may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Parecoxib is combined with Finerenone.Finerenone may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Pentamidine is combined with Finerenone.Finerenone may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Perindopril is combined with Finerenone.Finerenone may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Phosphoric acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Pinaverium is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Pindolol is combined with Finerenone.Finerenone may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pralidoxime which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Propafenone is combined with Finerenone.Finerenone may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Propranolol is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Propyphenazone is combined with Finerenone.Finerenone may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.The metabolism of Finerenone can be decreased when combined with Pyrimethamine.Finerenone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Quinapril is combined with Finerenone.Finerenone may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Ramipril is combined with Finerenone.Finerenone may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.The metabolism of Finerenone can be decreased when combined with Resmetirom.Finerenone may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.The metabolism of Finerenone can be increased when combined with Rifabutin.Finerenone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Sacubitril which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Salicylamide is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Salicylic acid is combined with Finerenone.Finerenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Salsalate is combined with Finerenone.Finerenone may increase the excretion rate of Saxagliptin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Selenious acid which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Selenium which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.The metabolism of Finerenone can be increased when combined with Somatrogon.The risk or severity of hyperkalemia can be increased when Sotalol is combined with Finerenone.Finerenone may increase the excretion rate of Streptomycin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Finerenone.Finerenone may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Sulindac is combined with Finerenone.Finerenone may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Synthetic Conjugated Estrogens, A which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Synthetic Conjugated Estrogens, B which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.The therapeutic efficacy of Finerenone can be decreased when used in combination with Tapentadol.Finerenone may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Technetium Tc-99m exametazime which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Technetium Tc-99m pyrophosphate which could result in a lower serum level and potentially a reduction in efficacy.The metabolism of Finerenone can be increased when combined with Tecovirimat.Finerenone may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Finerenone.Finerenone may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Testosterone propionate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Timolol is combined with Finerenone.Finerenone may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Finerenone.Finerenone may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tiotropium which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tirofiban which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tobramycin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tolazamide which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Finerenone.Finerenone may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Finerenone.Finerenone may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Finerenone.The risk or severity of hyperkalemia can be increased when Triamterene is combined with Finerenone.Finerenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Trimetrexate which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.The serum concentration of Finerenone can be increased when it is combined with Vadadustat.Finerenone may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Finerenone.Finerenone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hyperkalemia can be increased when Valsartan is combined with Finerenone.Finerenone may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.Finerenone may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of CNS depression can be increased when Finerenone is combined with Ziconotide.The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Finerenone.
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Kerendia®.
Abametapir
Amiodarone
Apalutamide
Atazanavir
Bexarotene
Bosentan
Brigatinib
Candesartan cilexetil
Carbamazepine
Clarithromycin
Clopidogrel
Conivaptan
Curcumin
Danazol
Darunavir
Dexamethasone
Dexamethasone acetate
Echinacea
Econazole
Efavirenz
Elvitegravir
Enzalutamide
Ergotamine
Etravirine
Felodipine
Fluorouracil
Fosphenytoin
Gemfibrozil
Indinavir
Itraconazole
Ketoconazole
Levoketoconazole
Lonafarnib
Lopinavir
Lumacaftor
Methimazole
Midostaurin
Mitotane
Modafinil
Mometasone furoate
Nafcillin
Nefazodone
Nelfinavir
Nilotinib
Paclitaxel
Pentobarbital
Phenobarbital
Phenytoin
Ponatinib
Posaconazole
Primidone
Ribociclib
Rifampin
Rifapentine
Ritonavir
Salmeterol
Saquinavir
Secobarbital
Spironolactone
Stiripentol
Telithromycin
Tipranavir
Voriconazole
Abatacept
Abiraterone
Acalabrutinib
Acetaminophen
Acetazolamide
Acetylsalicylic acid
Adagrasib
Adalimumab
Aldesleukin
Alfentanil
Almotriptan
Alpelisib
Amitriptyline
Anakinra
Anastrozole
Antipyrine
Apixaban
Apomorphine
Apremilast
Aprepitant
Atorvastatin
Avanafil
Azelastine
Benzhydrocodone
Benzyl alcohol
Berotralstat
Betamethasone
Bicalutamide
Bimekizumab
Bisacodyl
Bosutinib
Brentuximab vedotin
Bromocriptine
Buprenorphine
Butorphanol
Cabazitaxel
Cabergoline
Calcium polycarbophil
Canakinumab
Cannabidiol
Capsaicin
Carboxymethylcellulose
Castor oil
Celecoxib
Cenobamate
Ceritinib
Certolizumab pegol
Chloramphenicol
Chloroquine
Cimetidine
Ciprofloxacin
Citalopram
Clevidipine
Clozapine
Cobicistat
Codeine
Crizotinib
Cyclophosphamide
Cyclosporine
Dabrafenib
Dalfopristin
Daprodustat
Dapsone
Dasabuvir
Dasatinib
Daunorubicin
Deferasirox
Desipramine
Desvenlafaxine
Dextropropoxyphene
Diazepam
Diclofenac
Dihydrocodeine
Dihydroergotamine
Diltiazem
Dimethyl sulfoxide
Diphenoxylate
Dipotassium phosphate
Docetaxel
Docusate
Doxorubicin
Dronabinol
Dronedarone
Droxidopa
Elagolix
Elbasvir
Eltrombopag
Eluxadoline
Emapalumab
Enasidenib
Encorafenib
Epcoritamab
Ephedrine
Epinephrine
Erlotinib
Erythromycin
Estetrol
Estradiol
Estradiol acetate
Estradiol cypionate
Estradiol valerate
Eszopiclone
Etanercept
Ethanol
Ethinylestradiol
Etoposide
Etrasimod
Everolimus
Fedratinib
Fentanyl
Fexinidazole
Fluconazole
Fluticasone propionate
Fluvastatin
Fluvoxamine
Fosaprepitant
Fosnetupitant
Fostamatinib
Frangula purshiana bark
Fruquintinib
Fusidic acid
Genistein
Glasdegib
Glofitamab
Gluconic Acid
Glyburide
Glycerin
Golimumab
Haloperidol
Hydralazine
Hydrocodone
Hydrocortisone
Hydromorphone
Hydroxychloroquine
Ibuprofen
Idelalisib
Ifosfamide
Imatinib
Infliximab
Insulin aspart
Insulin degludec
Insulin detemir
Insulin glargine
Insulin glulisine
Insulin human
Insulin lispro
Iptacopan
Irbesartan
Isavuconazonium
Isoniazid
Isradipine
Istradefylline
Ivacaftor
Ivosidenib
Ketamine
Ketorolac
Lactitol
Lactulose
Lanreotide
Lansoprazole
Lapatinib
Letermovir
Levonordefrin
Levorphanol
Levothyroxine
Linaclotide
Linagliptin
Linzagolix
Lomitapide
Loperamide
Loratadine
Lubiprostone
Luliconazole
Magnesium
Magnesium acetate
Magnesium carbonate
Magnesium citrate
Magnesium glycinate
Magnesium hydroxide
Magnesium oxide
Magnesium sulfate
Magnesium trisilicate
Mannitol
Mavacamten
Mavorixafor
Medroxyprogesterone acetate
Mefloquine
Meloxicam
Meperidine
Methadone
Methylcellulose
Methylene blue
Methylergometrine
Metronidazole
Metyrapone
Miconazole
Midazolam
Mifepristone
Milnacipran
Mineral oil
Mirtazapine
Mitapivat
Monopotassium phosphate
Montelukast
Morphine
Mycophenolate mofetil
Nalbuphine
Naloxegol
Naltrexone
Naproxen
Netupitant
Nicardipine
Nilutamide
Nirogacestat
Nitric Oxide
Norepinephrine
Octreotide
Olaparib
Oliceridine
Olodaterol
Ombitasvir
Opium
Orphenadrine
Osilodrostat
Oxybutynin
Oxycodone
Oxymetholone
Oxymorphone
Ozanimod
Palbociclib
Paroxetine
Pasireotide
Pazopanib
Pentazocine
Peppermint oil
Phenelzine
Picosulfuric acid
Pimozide
Pioglitazone
Piperine
Piroxicam
Pirtobrutinib
Pitolisant
Plantago seed
Plecanatide
Polyethylene glycol
Potassium
Potassium acetate
Potassium bicarbonate
Potassium bitartrate
Potassium carbonate
Potassium cation
Potassium chloride
Potassium citrate
Potassium hydroxide
Potassium Iodide
Potassium nitrate
Potassium sulfate
Potassium triiodide
Pralsetinib
Prednisolone phosphate
Primaquine
Probenecid
Propofol
Prucalopride
Quinidine
Quinine
Quinupristin
Rabeprazole
Racepinephrine
Raloxifene
Ranolazine
Regorafenib
Remdesivir
Remifentanil
Repaglinide
Repotrectinib
Rilonacept
Rilpivirine
Riociguat
Ritlecitinib
Rosiglitazone
Rucaparib
Rutin
Sarilumab
Satralizumab
Secukinumab
Selegiline
Selexipag
Selpercatinib
Selumetinib
Senna leaf
Sennosides
Siltuximab
Simvastatin
Sitagliptin
Sodium ascorbate
Sodium cation
Sodium fluorophosphate
Sodium phosphate, dibasic
Sodium phosphate, dibasic, unspecified form
Sodium phosphate, monobasic
Sodium phosphate, monobasic, unspecified form
Sodium sulfate
Sorafenib
Sorbitol
Sotorasib
Sufentanil
Sulfadiazine
Sulfamethoxazole
Sulfate ion
Sunitinib
Tacrolimus
Tamoxifen
Tazarotene
Tegaserod
Telotristat ethyl
Teniposide
Terbinafine
Teriflunomide
Testosterone cypionate
Testosterone enanthate
Testosterone undecanoate
Tetracycline
Theophylline
Ticagrelor
Tioconazole
Tocilizumab
Topotecan
Torasemide
Tovorafenib
Tramadol
Tranylcypromine
Treosulfan
Treprostinil
Triclabendazole
Trimethoprim
Trofinetide
Tucatinib
Valproic acid
Velpatasvir
Vemurafenib
Venetoclax
Verapamil
Viloxazine
Vinblastine
Vortioxetine
Voxilaprevir
Zafirlukast
Zidovudine
Ziprasidone
Abacavir
Acebutolol
Aceclofenac
Aclidinium
Acrivastine
Acyclovir
Albuterol
Albutrepenonacog alfa
Aliskiren
Allopurinol
Almasilate
Alogliptin
Alprazolam
Amantadine
Amiloride
Amlodipine
Ammonium chloride
Amoxicillin
Amphetamine
Ampicillin
Antithrombin III human
Arformoterol
Arsenic trioxide
Atenolol
Atomoxetine
Auranofin
Azacitidine
Azathioprine
Azelaic acid
Azilsartan medoxomil
Aztreonam
Baclofen
Balsalazide
Baricitinib
Benazepril
Benzatropine
Benznidazole
Bepotastine
Betaxolol
Bicisate
Bismuth subgallate
Bisoprolol
Bleomycin
Brivaracetam
Budesonide
Bumetanide
Bupropion
Buspirone
Cabozantinib
Canagliflozin
Capecitabine
Capreomycin
Captopril
Carbidopa
Carboplatin
Carmustine
Carvedilol
Cefaclor
Cefadroxil
Cefdinir
Cefotetan
Ceftazidime
Ceftibuten
Ceftolozane
Ceftriaxone
Cephalexin
Cetirizine
Cevimeline
Chlorpromazine
Chlorzoxazone
Choline salicylate
Chondroitin sulfate
Chromic chloride
Chromium
Chromium nicotinate
Cidofovir
Cilostazol
Cisplatin
Clobazam
Clofarabine
Clomipramine
Clonazepam
Clorazepic acid
Clove oil
Colchicine
Conjugated estrogens
Cyanocobalamin
Dabigatran etexilate
Dacarbazine
Dalfampridine
Dalteparin
Dantrolene
Daptomycin
Deferiprone
Delafloxacin
Desmopressin
Deutetrabenazine
Dexmedetomidine
Dexpanthenol
Dexrazoxane
Dextran
Diatrizoate
Dicyclomine
Didanosine
Dienogest
Diflunisal
Digoxin
Dimercaprol
Disopyramide
DL-Methylephedrine
Dobutamine
Dopamine
Doxepin
Doxycycline
Drospirenone
Duloxetine
Edoxaban
Edrophonium
Empagliflozin
Enalapril
Enalaprilat
Enoxaparin
Eplerenone
Epoprostenol
Eprosartan
Ertapenem
Esmolol
Estazolam
Estrone sulfate
Ethambutol
Ethenzamide
Ethosuximide
Etodolac
Etomidate
Etonogestrel
Eucalyptus oil
Evening primrose oil
Fenofibrate
Fenofibric acid
Fenoldopam
Fenoprofen
Fesoterodine
Fish oil
Flavoxate
Florbetaben F-18
Florbetapir F-18
Floxuridine
Flucytosine
Fludeoxyglucose (18F)
Flumazenil
Fluocinolone acetonide
Flurazepam
Flurbiprofen
Flutamide
Folic acid
Fomepizole
Fondaparinux
Fosfomycin
Fosinopril
Furosemide
Gabapentin enacarbil
Gadobenic acid
Gadodiamide
Gadofosveset trisodium
Gadoteric acid
Gadoteridol
Ganciclovir
Gemcitabine
Glipizide
Glycerol phenylbutyrate
Golodirsen
Goserelin
Guanfacine
Heparin
Hydroxocobalamin
Hydroxyethyl Starch
Ibutilide
Icatibant
Icosapent
Idarucizumab
Imipramine
Indapamide
Indigotindisulfonic acid
Indomethacin
Inositol
Iobenguane sulfate I-123
Iodixanol
Ioflupane I-123
Iopromide
Iothalamic acid
Ioversol
Ipecac
Ipilimumab
Isosorbide mononitrate
Isosulfan blue
Isotretinoin
Ixazomib
Ketoprofen
Labetalol
Lamivudine
Lamotrigine
Landiolol
Ledipasvir
Lenalidomide
Leuprolide
Levocarnitine
Levocetirizine
Levofloxacin
Levomenthol
Levomilnacipran
Levosalbutamol
Liothyronine
Lisinopril
Lithium carbonate
Lixisenatide
Lofexidine
Lorazepam
Losartan
Macitentan
Magnesium chloride
Magnesium salicylate
Maprotiline
Mecamylamine
Meclofenamic acid
Mefenamic acid
Megestrol acetate
Memantine
Mepivacaine
Meropenem
Mesalazine
Metamfetamine
Metaxalone
Metformin
Methotrexate
Methoxsalen
Methsuximide
Methyldopa
Methylnaltrexone
Methyltestosterone
Metoclopramide
Metolazone
Metoprolol
Metreleptin
Migalastat
Milrinone
Mirabegron
Moexipril
Mycophenolic acid
N-acetyltyrosine
Nabumetone
Nadolol
Naldemedine
Nalmefene
Naloxone
Nateglinide
Nebivolol
Nedocromil
Nifedipine
Nimodipine
Nisoldipine
Nitrofurantoin
Nitroprusside
Octinoxate
Olmesartan
Omaveloxolone
Oseltamivir
Oxacillin
Oxaprozin
Oxazepam
Oxybenzone
Oxyquinoline
Paliperidone
Palonosetron
Pantoprazole
Parecoxib
Pemetrexed
Pentamidine
Pentetic acid
Pentostatin
Pentoxifylline
Perindopril
Permethrin
Phenazopyridine
Phosphoric acid
Phylloquinone
Pinaverium
Pindolol
Piperacillin
Plazomicin
Plerixafor
Pomalidomide
Pralatrexate
Pralidoxime
Pramipexole
Prasugrel
Prednisone
Pregabalin
Procainamide
Procaine benzylpenicillin
Promethazine
Propafenone
Propantheline
Propranolol
Propyphenazone
Pyrantel
Pyrazinamide
Pyridoxine
Pyrimethamine
Quetiapine
Quinapril
Ramelteon
Ramipril
Ranitidine
Rasagiline
Reserpine
Resmetirom
Resorcinol
Ribavirin
Rifabutin
Rivaroxaban
Rizatriptan
Roflumilast
Ropivacaine
Ruxolitinib
Sacubitril
Salicylamide
Salicylic acid
Salmon calcitonin
Salsalate
Saxagliptin
Selenious acid
Selenium
Sodium acetate
Sodium fluoride
Sofosbuvir
Solriamfetol
Somatrogon
Sotalol
Streptomycin
Succinylcholine
Sucralfate
Sulbactam
Sulfasalazine
Sulindac
Sumatriptan
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, B
Tadalafil
Tamsulosin
Tapentadol
Tasimelteon
Technetium Tc-99m exametazime
Technetium Tc-99m pyrophosphate
Tecovirimat
Teduglutide
Telavancin
Telmisartan
Temazepam
Temozolomide
Tenofovir disoproxil
Terbutaline
Testosterone
Testosterone propionate
Tetradecyl hydrogen sulfate (ester)
Ticlopidine
Timolol
Tinidazole
Tinzaparin
Tiopronin
Tiotropium
Tirofiban
Tixocortol
Tobramycin
Tocopherol
Tolazamide
Tolcapone
Tolmetin
Tolterodine
Tolvaptan
Topiramate
Trametinib
Trandolapril
Triamterene
Triazolam
Triethylenetetramine
Trifluridine
Trimetrexate
Vaborbactam
Vadadustat
Valaciclovir
Valbenazine
Valdecoxib
Valganciclovir
Valsartan
Vancomycin
Varenicline
Venlafaxine
Vilanterol
Warfarin
Zaleplon
Zanamivir
Ziconotide
Zonisamide